Investors of Park Ha Biological Technology Co., Ltd. are being invited to serve as lead plaintiffs in a securities class action alleging unlawful statements during the Dec 2024–Jul 2025 period
Executive summary: Rosen Law Firm announced a class action lawsuit on behalf of purchasers of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) securities acquired between December 27, 2024 and July 8, 2025. The lawsuit alleges violations of securities laws and could result in financial liability for the company, affecting investor confidence and potentially triggering costly litigation.
Who is involved: Rosen Law Firm (plaintiff counsel), purchasers of PHH/BYAH securities during the class period, and Park Ha Biological Technology Co., Ltd. (defendant).
Likely next: The court will appoint a lead plaintiff, after which discovery proceedings will begin, potentially leading to a settlement or trial.
Rosen Law Firm filed the class action on July 31, 2026, covering shares bought between December 27, 2024 and July 8, 2025. The suit claims the company made misleading statements that inflated its stock price, exposing it to potential damages and legal costs. While the lawsuit does not allege fraud, it highlights ongoing scrutiny of biotech firms' disclosures. The outcome could affect the company's financial reserves and influence how similar firms manage investor communications.
Timeline
- — PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit (PR Newswire)
- — BYAH Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Park Ha Biological Technology Co., Ltd. (PR Newswire)
Analysis — what this means
Sectors affected
- Biotechnology
Historical parallels
- Rosen Law Firm announcement July 30, 2026 about same Park Ha Biological Technology class action
Key entities
Sources
- PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit — PR Newswire
- BYAH Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Park Ha Biological Technology Co., Ltd. — PR Newswire
Related cases
- Investors with over $100k losses in Park Ha Biological can step forward as lead plaintiffs in a securities lawsuit reiterated by Rosen Law Firm
- Rosen Law Firm alerts Park Ha Biological Technology investors to a lead plaintiff opportunity in an ongoing securities class action
- Robbins LLP has filed a securities class action on behalf of Park Ha Biological Technology (BYAH) investors, signaling potential legal and financial repercussions for the biotech firm
- Rosen Law Firm reminds investors of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) of lead plaintiff opportunity in securities class action covering Dec 27, 2024–Jul 8, 2025 purchases
- Park Ha Biological unveils an AI nutritionist to broaden its AI-driven skincare platform